To facilitate clinical management of Hp infection, serum anti-CagA and/or anti-VacA positive was defined as virulent Hp-I infection, while neither anti-CagA nor anti-VacA positive was defined as avirulent Hp-II infection. This evidence concerns the gene S100A8 and infection.